PharmaTher Files With FDA For Orphan Drug Designation In Use Of Ketamine For ALS
PharmaTher Holdings (CSE: PHRM) this morning announced that it has filed with the US FDA for orphan drug designation as
Read morePharmaTher Holdings (CSE: PHRM) this morning announced that it has filed with the US FDA for orphan drug designation as
Read morePharmaTher Holdings (CSE: PHRM) has seen the US FDA approve the firms application for an investigational new drug. The approval
Read morePharmaTher Inc (CSE: PHRM) has entered into an exclusive worldwide license agreement for the development and commercialization of a patented
Read moreToday on the Daily Dive, Fabio Chianelli, CEO of PharmaTher Inc (CSE: PHRM) sits down with our host Cassandra Leah
Read moreSuicidal ideation is an emergent condition that demands immediate attention. It has been shown that the time between decision and
Read more